E. coli has a natural tendency to travel through the body and specifically colonize and grow inside tumor cores. A recent study by researchers from Columbia University harnessed this trait and genetically engineered a probiotic strain of the bacterium to produce an enzyme called cytosine deaminase (CD) that anchors to tumor tissue. This allows it to convert 5-FC, a nontoxic prodrug that remains harmless in the body until activated, into 5-FU, a powerful cancer-killing chemotherapy drug, directly inside the tumor.